Effects of Canagliflozin and Metformin on Insulin Resistance and Visceral Adipose Tissue in Newly-Diagnosed T2D
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
BMC Endocrine Disorders
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effects of canagliflozin and metformin on insulin resistance and visceral adipose tissue in people with newly-diagnosed type 2 diabetes
BMC Endocr Disord 2022 Feb 10;22(1)37, Z Hao, Y Sun, G Li, Y Shen, Y Wen, Y LiuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.